T1	Participants 450 490	64 patients, were enrolled in the study.
T2	Participants 705 724	Patients in group I
T3	Participants 802 812	group II r
T4	Participants 937 947	Two groups
T5	Participants 1051 1058	Group 1
T6	Participants 1066 1073	group 2
T7	Participants 1183 1193	two groups
T8	Participants 1320 1327	group 1
T9	Participants 1350 1357	group 2
T10	Participants 1401 1409	patients
T11	Participants 1308 1316	patients
T12	Participants 1459 1472	group 1 and 2
T13	Participants 1605 1618	group 1 and 2
T14	Participants 1680 1690	two groups
